About Pierre Fabre Laboratories

Pierre Fabre Laboratories is the world’s second-largest dermo-cosmetics company and one of Europe’s leading pharmaceutical laboratories. Its Dermo-cosmetics & Personal Care portfolio includes international brands such as  Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, Même Cosmetics, Darrow and Elgydium. Its Medical Care activity covers 5 main therapeutic fields: oncology, dermatology, rare diseases primary care and family health care.   

In 2024, Pierre Fabre Laboratories posted 3.1 billion euros in revenues, 71% of which came from international sales in 120 countries. Based in southwest France since its creation and manufacturing more than 90% of its products in France, Pierre Fabre Laboratories employs 10,200 people worldwide. Its R&D budget amounted to 219 million euros in 2024, of which 60% was allocated to targeted therapies in oncology and 35% to skin health and care solutions.   

Pierre Fabre Laboratories’ majority shareholder (86%) is an eponymous Foundation, which is recognized by the French government as being a public-interest foundation. Employees constitute the company’s other shareholder. This capital structure guarantees the company’s independence, long-term vision and contribution to the common good. The dividends paid to the Pierre Fabre Foundation contribute to 35 healthcare-access programs deployed in 22 of the least developed countries in the world.  

Pierre Fabre Laboratories’ CSR policy has been assessed by AFNOR Certification and has been awarded the “Exemplary” level of its CSR label (ISO 26 000 standard for sustainable development). 

For more information, visit www.pierre-fabre.com, @Laboratoires Pierre Fabre, @Pierre Fabre Oncology

Updated May 2025